NCT06262061View on ClinicalTrials.gov

Propranolol for the Treatment of Traumatic Brain Injury

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2025

Conditions
TBI (Traumatic Brain Injury)
Interventions
DRUG

Propranolol

20mg oral propranolol BID x 14 days

DRUG

Placebo

Placebo pill orally BID x 14 days

Sponsors
All Listed Sponsors
lead

London Health Sciences Centre

OTHER

NCT06262061 - Propranolol for the Treatment of Traumatic Brain Injury | Biotech Hunter | Biotech Hunter